ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Windtree Therapeutics Inc (PK)

Windtree Therapeutics Inc (PK) (WINT)

0.0144
0.00
(0.00%)
終了 6月6日 5:00AM

Windtree Therapeutics Inc (PK) (WINT) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
0.0144
( - )
買値
0.0143
売値
0.019
出来高
54,682
0.0143 日の範囲 0.0161
0.007135 52 週間の範囲 7.75
時価総額
前日終値
0.0144
始値
0.0144
最終取引時間
財務取引量
US$ 844
VWAP
0.015439
平均取引量 (3 か月)
US$ 354,363
発行済株式数
44,987,863
配当利回り
PER
-0
1 株当たり利益 (EPS)
-5.9
歳入
-
純利益
-39.99M

Windtree Therapeutics Inc (PK) について

Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for t... Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trials to treat respiratory distress syndrome in premature infants; Surfaxin, a lyophilized KL4 surfactant for the treatment of respiratory disease, disorder, or condition in humans; Rostafuroxin, which is in Phase 2b clinical trials for the treatment of genetically associated hypertension; and oral and intravenous SERCA2a activators, which are in preclinical trials for the treatment of chronic and acute heart failure. In addition, it is developing an aPKCi inhibitor, which is in preclinical trials for the treatment of cutaneous malignancies and solid tumors. Windtree Therapeutics, Inc. has a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sale of a portfolio of potential KL4 surfactant products; a license, development, and commercialization agreement with Lee’s Pharmaceutical (HK) Ltd. and Zhaoke Pharmaceutical (Hefei) Co. Ltd.; a license agreement with Philip Morris USA, Inc. and Johnson & Johnson; and a collaboration with Battelle Memorial Institute for the development of its aerosol delivery system. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was founded in 1992 and is headquartered in Warrington, Pennsylvania. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Warrington, United States
設立
1992
Windtree Therapeutics Inc (PK) is listed in the Healthcare sector of the その他OTC with ticker WINT. The last closing price for Windtree Therapeutics (PK) was US$0.01. Over the last year, Windtree Therapeutics (PK) shares have traded in a share price range of US$ 0.007135 to US$ 7.75.

Windtree Therapeutics (PK) currently has 44,987,863 shares in issue. The market capitalisation of Windtree Therapeutics (PK) is US$647,825.23 . Windtree Therapeutics (PK) has a price to earnings ratio (PE ratio) of -0.00.

WINT 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.001612.50.01280.01790.0121591310.01488087CS
4-0.0056-280.020.02250.011233270.01605288CS
120.0054600.0090.0340.0093407420.01537726CS
26-0.0465-76.3546798030.06090.0650.0071353463950.01909511CS
52-7.7356-99.81419354847.757.750.0071354180190.05939019CS
156-7.7356-99.81419354847.757.750.0071354058440.05939019CS
260-7.7356-99.81419354847.757.750.0071353943580.05939019CS

WINT - Frequently Asked Questions (FAQ)

What is the current Windtree Therapeutics Inc (PK) share price?
The current share price of Windtree Therapeutics Inc (PK) is US$ 0.0144
How many Windtree Therapeutics Inc (PK) shares are in issue?
Windtree Therapeutics Inc (PK) has 44,987,863 shares in issue
What is the market cap of Windtree Therapeutics Inc (PK)?
The market capitalisation of Windtree Therapeutics Inc (PK) is USD 647.83k
What is the 1 year trading range for Windtree Therapeutics Inc (PK) share price?
Windtree Therapeutics Inc (PK) has traded in the range of US$ 0.007135 to US$ 7.75 during the past year
What is the PE ratio of Windtree Therapeutics Inc (PK)?
The price to earnings ratio of Windtree Therapeutics Inc (PK) is -0
What is the registered address of Windtree Therapeutics Inc (PK)?
The registered address for Windtree Therapeutics Inc (PK) is 2600 Kelly Road, Warrington, Pennsylvania, 18976-3622
What is the Windtree Therapeutics Inc (PK) website address?
The website address for Windtree Therapeutics Inc (PK) is windtreetx.com
Which industry sector does Windtree Therapeutics Inc (PK) operate in?
Windtree Therapeutics Inc (PK) operates in the Biotechnology & Life Sciences sector

WINT 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード